EW Healthcare Partners, L.P. Insider Trading Activity

Also formerly known as Essex Woodlands Fund IX, L.P.
Average Profitability
60.73%
Insider Buys Quantity
4
Insider Buys Sum
$37.52M
Insider Sells Quantity
10
Insider Sells Sum
$53.48M

Insider Activity of EW Healthcare Partners, L.P.

Biography of EW Healthcare Partners, L.P.

No biography is available at this moment.

2023-09-01SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
20,000
0.054%
$9.90$197,982+3.47%
2023-08-31SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
78,495
0.2319%
$10.24$804,061+9.08%
2023-08-30SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
60,976
0.1736%
$10.92$666,147-2.53%
2023-08-29SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
87,854
0.2561%
$10.75$944,225+3.67%
2023-08-28SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
60,858
0.1749%
$11.71$712,653-6.57%
2023-08-25SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
84,656
0.2354%
$11.00$931,327-2.48%
2023-08-24SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
139,280
0.3637%
$11.17$1.56M-3.91%
2023-08-23SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
121,103
0.3695%
$13.05$1.58M-4.77%
2023-08-22SaleEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
46,778
0.1337%
$14.62$683,834-23.94%
2018-06-25PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
16.86M
19.9567%
$1.26$21.33M+13.99%
2018-03-28PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
8.61M
19.384%
$1.10$9.47M+107.48%
2017-11-20SaleAxoGen, Inc.
AXGN
10 percent owner
2.3M
5.5203%
$19.74$45.4M+51.03%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.